The Race for a Vaccine, What's Next?

Monday, Moderna said it is submitting its COVID-19 vaccine to the U.S. Food and Drug Administration for emergency use authorization, becoming the second company to do so. One former FDA official says this isn’t an individual race, though, it’s a relay race. So what’s next?